Does Baseline Body Mass Index, Fasting Blood Sugar, and High-Sensitivity C-Reactive Protein Influence the Efficacy of Adding Ezetimibe to Atorvastatin Versus Doubling the Atorvastatin Dose in Moderately High and High Coronary Heart Disease Risk Patients?

✍ Scribed by Harold Edward Bays; Scott Conard; Lawrence A. Leiter; Steven Bird; Arvind K. Shah; Jianxin Lin; Robert S. Lowe; Andrew M. Tershakovec

• Book ID: 119287726
• Publisher: Elsevier
• Year: 2009
• Tongue: English
• Weight: 268 KB
• Volume: 3
• Category: Article
• ISSN: 1933-2874
• DOI: 10.1016/j.jacl.2009.04.027